Having considered the comments and recommendations of the Sub-Committee on Monitoring, Evaluation and Finance (UNEP/OzL.Pro/ExCom/36/4, para. 24), the Executive Committee decided:
(a) To endorse the 2002 business plan of UNDP, as contained in UNEP/OzL.Pro/ExCom/36/10 and UNEP/OzL.Pro/ExCom/36/10/Corr.1, with the amendment in subparagraph (d) below while noting that endorsement did not denote approval of the projects identified therein nor their funding levels;
(b) To request UNEP and UNDP to redouble their efforts for the implementation of RMPs in Bangladesh and Niger;
(c) In light of its recommendation on the consolidated 2002 business plan, also to request UNDP to provide an addendum to its 2002 business plan for submission to the 37th meeting of the Executive Committee, as appropriate, including the actions it would take to expedite the implementation of approved projects and those critical to compliance;
(d) To approve the performance indicators for UNDP, set out in Tables 1 and 2 of the Fund Secretariat’s comments in UNEP/OzL.Pro/ExCom/36/10, noting that UNDP had changed its target for phase-out from non-investment activities from 120 to 160 ODP tonnes (Annex II to the present report);
(e) To request the Secretariat to prepare draft guidelines for Metered Dose Inhaler (MDI) projects for consideration by the Executive Committee at its 37th meeting.